TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 41 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $472 | +140.8% | 26,566 | +145.0% | 0.00% | – |
| Q2 2023 | $196 | +20.2% | 10,842 | -16.4% | 0.00% | – |
| Q1 2023 | $163 | -14.2% | 12,965 | 0.0% | 0.00% | – |
| Q4 2022 | $190 | -99.9% | 12,965 | +0.1% | 0.00% | – |
| Q3 2022 | $222,000 | +18.1% | 12,948 | +0.7% | 0.00% | – |
| Q2 2022 | $188,000 | +89.9% | 12,860 | +118.7% | 0.00% | – |
| Q1 2022 | $99,000 | -25.0% | 5,881 | +0.2% | 0.00% | – |
| Q4 2021 | $132,000 | +3.9% | 5,872 | -0.2% | 0.00% | – |
| Q3 2021 | $127,000 | -53.1% | 5,881 | -37.1% | 0.00% | – |
| Q2 2021 | $271,000 | +42.6% | 9,353 | +58.5% | 0.00% | – |
| Q1 2021 | $190,000 | +31.0% | 5,900 | +68.6% | 0.00% | – |
| Q4 2020 | $145,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |